Correlation Between Sabre Insurance and Cizzle Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sabre Insurance and Cizzle Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sabre Insurance and Cizzle Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sabre Insurance Group and Cizzle Biotechnology Holdings, you can compare the effects of market volatilities on Sabre Insurance and Cizzle Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sabre Insurance with a short position of Cizzle Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sabre Insurance and Cizzle Biotechnology.

Diversification Opportunities for Sabre Insurance and Cizzle Biotechnology

-0.21
  Correlation Coefficient

Very good diversification

The 3 months correlation between Sabre and Cizzle is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Sabre Insurance Group and Cizzle Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cizzle Biotechnology and Sabre Insurance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sabre Insurance Group are associated (or correlated) with Cizzle Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cizzle Biotechnology has no effect on the direction of Sabre Insurance i.e., Sabre Insurance and Cizzle Biotechnology go up and down completely randomly.

Pair Corralation between Sabre Insurance and Cizzle Biotechnology

Assuming the 90 days trading horizon Sabre Insurance Group is expected to generate 0.43 times more return on investment than Cizzle Biotechnology. However, Sabre Insurance Group is 2.33 times less risky than Cizzle Biotechnology. It trades about -0.14 of its potential returns per unit of risk. Cizzle Biotechnology Holdings is currently generating about -0.13 per unit of risk. If you would invest  13,740  in Sabre Insurance Group on September 3, 2024 and sell it today you would lose (620.00) from holding Sabre Insurance Group or give up 4.51% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sabre Insurance Group  vs.  Cizzle Biotechnology Holdings

 Performance 
       Timeline  
Sabre Insurance Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sabre Insurance Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Cizzle Biotechnology 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Cizzle Biotechnology Holdings are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Cizzle Biotechnology exhibited solid returns over the last few months and may actually be approaching a breakup point.

Sabre Insurance and Cizzle Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sabre Insurance and Cizzle Biotechnology

The main advantage of trading using opposite Sabre Insurance and Cizzle Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sabre Insurance position performs unexpectedly, Cizzle Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cizzle Biotechnology will offset losses from the drop in Cizzle Biotechnology's long position.
The idea behind Sabre Insurance Group and Cizzle Biotechnology Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios